What is INNEOVA HOLD's earnings per share (EPS)?

INNEOVA HOLD (INEO) reported diluted earnings per share of $-0.03 for fiscal year 2025. This represents a -175.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

INNEOVA HOLD Financials

INEO

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows INNEOVA HOLD (INEO) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI INEO FY2025 2026-05-15

A working-capital-driven cash surge masked a cost-heavier operating model as overhead expansion pushed core profit below break-even.

Gross margin improved from 18.3% to 19.2%, yet operating profit slipped below break-even because overhead kept rising instead of being absorbed by stable sales. At the same time, receivables fell to $7.9M and capex dropped to $10K, so the cash-flow improvement looks more like working-capital release and unusually light reinvestment than a stronger earnings engine, especially with net income turning negative.

This remains a thin-margin business: SG&A climbed from $8.5M to $10.1M, which consumed the modest improvement in product-level economics. That pattern points to negative operating leverage rather than a demand problem alone, because slightly better gross profitability still did not reach the operating line.

The balance sheet offers only a narrow cushion despite better cash generation. With a current ratio of 1.1x and cash of just $1.1M, liquidity still depends heavily on turning working capital efficiently rather than holding excess cash. Meanwhile, debt-to-equity moved from 0.2x to 0.6x, showing that shrinking equity made the financing posture less forgiving even without a large absolute debt load.

Financial Health Signals

Financial Profile 38/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of INNEOVA HOLD's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

INNEOVA HOLD has an operating margin of -0.1%, meaning the company retains $-0 of operating profit per $100 of revenue. This below-average margin results in a low score of 25/100, suggesting thin profitability after operating expenses. This is down from 2.0% the prior year.

Growth

INNEOVA HOLD's revenue declined 6.9% year-over-year, from $62.7M to $58.4M. This contraction results in a growth score of 28/100.

Leverage

INNEOVA HOLD carries a low D/E ratio of 0.25, meaning only $0.25 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 97/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

INNEOVA HOLD's current ratio of 1.06 is below the typical benchmark, resulting in a score of 16/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

INNEOVA HOLD has a free cash flow margin of 7.6%, earning a moderate score of 39/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

INNEOVA HOLD generates a -8.0% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 24/100. This is down from 7.7% the prior year.

Piotroski F-Score Neutral

4/9

INNEOVA HOLD passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Mixed

-11.19x

For every $1 of reported earnings, INNEOVA HOLD generates $-11.19 in operating cash flow ($4.4M OCF vs -$397K net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage At Risk

-0.0x

INNEOVA HOLD earns $-0.0 in operating income for every $1 of interest expense (-$51K vs $1.3M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$58.4M

YoY-6.9%

INNEOVA HOLD generated $58.4M in revenue in fiscal year 2025. This represents a decrease of 6.9% from the prior year.

EBITDA

$424K

YoY-73.3%

INNEOVA HOLD's EBITDA was $424K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 73.3% from the prior year.

Net Income

-$397K

YoY-205.6%

INNEOVA HOLD reported -$397K in net income in fiscal year 2025. This represents a decrease of 205.6% from the prior year.

EPS (Diluted)

$-0.03

YoY-175.0%

INNEOVA HOLD earned $-0.03 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 175.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$4.4M

YoY+146.9%

INNEOVA HOLD generated $4.4M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 146.9% from the prior year.

Cash & Debt

$1.1M

YoY-40.8%

INNEOVA HOLD held $1.1M in cash against $1.2M in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

17M

YoY+67.4%

INNEOVA HOLD had 17M shares outstanding in fiscal year 2025. This represents an increase of 67.4% from the prior year.

Margins & Returns

Gross Margin

19.2%

YoY-0.4pp

INNEOVA HOLD's gross margin was 19.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 0.4 percentage points from the prior year.

Operating Margin

-0.1%

YoY-2.1pp

INNEOVA HOLD's operating margin was -0.1% in fiscal year 2025, reflecting core business profitability. This is down 2.1 percentage points from the prior year.

Net Margin

-0.7%

YoY-1.3pp

INNEOVA HOLD's net profit margin was -0.7% in fiscal year 2025, showing the share of revenue converted to profit. This is down 1.3 percentage points from the prior year.

Return on Equity

-8.0%

YoY-15.6pp

INNEOVA HOLD's ROE was -8.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 15.6 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

$10K

YoY-98.6%

INNEOVA HOLD invested $10K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 98.6% from the prior year.

INEO Income Statement

Metric	FY25	FY24	FY23	FY22
Revenue	$58.4M-6.9%	$62.7M+0.1%	$62.7M+21.9%	$51.4M
Cost of Revenue	$47.2M-6.4%	$50.4M-0.5%	$50.7M+20.2%	$42.2M
Gross Profit	$11.2M-8.8%	$12.3M+2.6%	$12.0M+29.3%	$9.3M
R&D Expenses	N/A	N/A	N/A	N/A
SG&A Expenses	$10.1M+7.9%	$9.4M+21.7%	$7.7M+28.7%	$6.0M
Operating Income	-$51K-104.1%	$1.2M-56.3%	$2.9M+77.3%	$1.6M
Interest Expense	$1.3M-7.2%	$1.4M+29.6%	$1.1M+76.3%	$634K
Income Tax	-$656K-624.8%	$125K-56.1%	$285K-12.3%	$325K
Net Income	-$397K-205.6%	$376K-79.8%	$1.9M+21.8%	$1.5M
EPS (Diluted)	$-0.03-175.0%	$0.04-80.0%	$0.20+24900.0%	$0.00

Metric	Q4'25	Q2'25	Q4'24	Q2'24	Q4'23	Q4'22
Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	N/A	N/A	N/A	N/A	N/A	N/A
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A

INEO Balance Sheet

Metric	FY25	FY24	FY23	FY22
Total Assets	$41.4M-9.5%	$45.8M+3.7%	$44.2M+9.5%	$40.3M
Current Assets	$36.5M-11.5%	$41.3M+9.8%	$37.6M	N/A
Cash & Equivalents	$1.1M-40.8%	$1.8M+159.4%	$690K	N/A
Inventory	$18.6M-4.3%	$19.4M+2.3%	$19.0M	N/A
Accounts Receivable	$10.6M-19.7%	$13.2M-9.6%	$14.6M	N/A
Goodwill	N/A	N/A	N/A	N/A
Total Liabilities	$36.4M-10.8%	$40.9M+13.5%	$36.0M-3.3%	$37.2M
Current Liabilities	$34.4M-7.0%	$37.0M+7.5%	$34.5M	N/A
Long-Term Debt	$1.2M-60.0%	$3.1M+213.1%	$991K	N/A
Total Equity	$5.0M+1.3%	$4.9M-2.9%	$5.1M+64.0%	$3.1M
Retained Earnings	$4.5M-8.1%	$4.9M+170.8%	$1.8M	N/A

Metric	Q4'25	Q2'25	Q4'24	Q2'24	Q4'23	Q4'22
Total Assets	$41.4M-21.2%	$52.6M+14.9%	$45.8M+15.6%	$39.6M-10.3%	$44.2M+9.5%	$40.3M
Current Assets	$36.5M-14.0%	$42.5M+2.9%	$41.3M	N/A	$37.6M	N/A
Cash & Equivalents	$1.1M-50.5%	$2.1M+19.5%	$1.8M+112.6%	$842K+22.0%	$690K	N/A
Inventory	$18.6M+2.0%	$18.2M-6.2%	$19.4M	N/A	$19.0M	N/A
Accounts Receivable	$10.6M-14.8%	$12.4M-5.8%	$13.2M	N/A	$14.6M	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$36.4M-12.0%	$41.4M+1.4%	$40.9M+11.5%	$36.7M+1.8%	$36.0M-3.3%	$37.2M
Current Liabilities	$34.4M-8.4%	$37.6M+1.6%	$37.0M	N/A	$34.5M	N/A
Long-Term Debt	$1.2M-57.3%	$2.9M-6.4%	$3.1M	N/A	$991K	N/A
Total Equity	$5.0M-55.5%	$11.2M+127.4%	$4.9M+66.0%	$3.0M-41.5%	$5.1M+64.0%	$3.1M
Retained Earnings	$4.5M+118.5%	$2.1M-57.9%	$4.9M	N/A	$1.8M	N/A

INEO Cash Flow Statement

Metric	FY25	FY24	FY23	FY22
Operating Cash Flow	$4.4M+75.3%	$2.5M-32.2%	$3.7M+281.9%	-$2.1M
Capital Expenditures	$10K-98.6%	$739K+139.2%	$309K+9.2%	$283K
Free Cash Flow	$4.4M+146.9%	$1.8M-47.7%	$3.4M+246.6%	-$2.3M
Investing Cash Flow	-$10K+98.6%	-$739K-139.2%	-$309K-9.2%	-$283K
Financing Cash Flow	-$5.5M-769.6%	-$628K+83.5%	-$3.8M-278.4%	$2.1M
Dividends Paid	N/A	N/A	N/A	$1.5M
Share Buybacks	N/A	N/A	N/A	N/A

Metric	Q4'25	Q2'25	Q4'24	Q2'24	Q4'23	Q4'22
Operating Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

INEO Financial Ratios

Metric	FY25	FY24	FY23	FY22
Gross Margin	19.2%-0.4pp	19.6%+0.5pp	19.1%+1.1pp	18.0%
Operating Margin	-0.1%-2.1pp	2.0%-2.6pp	4.5%+1.4pp	3.1%
Net Margin	-0.7%-1.3pp	0.6%-2.4pp	3.0%0.0pp	3.0%
Return on Equity	-8.0%-15.6pp	7.7%-29.1pp	36.8%-12.7pp	49.5%
Return on Assets	-1.0%-1.8pp	0.8%-3.4pp	4.2%+0.4pp	3.8%
Current Ratio	1.06-0.1	1.11+0.0	1.09	N/A
Debt-to-Equity	0.25-0.4	0.63+0.4	0.20-11.9	12.07
FCF Margin	7.6%+4.7pp	2.9%-2.6pp	5.5%+10.0pp	-4.5%

Metric	Q4'25	Q2'25	Q4'24	Q2'24	Q4'23	Q4'22
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	1.06-0.1	1.13+0.0	1.11	N/A	1.09	N/A
Debt-to-Equity	0.25-0.0	0.26-0.4	0.63-11.8	12.39+12.2	0.20-11.9	12.07
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

AMV

$17.8M

Ree Automotive REE

$12.7M

Greenland Technologies Hldg GTEC

$17.0M

Worksport Ltd WKSP

$9.5M

Foresight Autonomous Hldgs Ltd FRSX

$4.9M

Frequently Asked Questions

What is INNEOVA HOLD's annual revenue?

INNEOVA HOLD (INEO) reported $58.4M in total revenue for fiscal year 2025. This represents a -6.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is INNEOVA HOLD's revenue growing?

INNEOVA HOLD (INEO) revenue declined by 6.9% year-over-year, from $62.7M to $58.4M in fiscal year 2025.

Is INNEOVA HOLD profitable?

No, INNEOVA HOLD (INEO) reported a net income of -$397K in fiscal year 2025, with a net profit margin of -0.7%.

What is INNEOVA HOLD's EBITDA?

INNEOVA HOLD (INEO) had EBITDA of $424K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does INNEOVA HOLD have?

As of fiscal year 2025, INNEOVA HOLD (INEO) had $1.1M in cash and equivalents against $1.2M in long-term debt.

What is INNEOVA HOLD's gross margin?

INNEOVA HOLD (INEO) had a gross margin of 19.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is INNEOVA HOLD's operating margin?

INNEOVA HOLD (INEO) had an operating margin of -0.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is INNEOVA HOLD's net profit margin?

INNEOVA HOLD (INEO) had a net profit margin of -0.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is INNEOVA HOLD's return on equity (ROE)?

INNEOVA HOLD (INEO) has a return on equity of -8.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is INNEOVA HOLD's free cash flow?

INNEOVA HOLD (INEO) generated $4.4M in free cash flow during fiscal year 2025. This represents a 146.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is INNEOVA HOLD's operating cash flow?

INNEOVA HOLD (INEO) generated $4.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are INNEOVA HOLD's total assets?

INNEOVA HOLD (INEO) had $41.4M in total assets as of fiscal year 2025, including both current and long-term assets.

What are INNEOVA HOLD's capital expenditures?

INNEOVA HOLD (INEO) invested $10K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does INNEOVA HOLD have outstanding?

INNEOVA HOLD (INEO) had 17M shares outstanding as of fiscal year 2025.

What is INNEOVA HOLD's current ratio?

INNEOVA HOLD (INEO) had a current ratio of 1.06 as of fiscal year 2025, which is considered adequate.

What is INNEOVA HOLD's debt-to-equity ratio?

INNEOVA HOLD (INEO) had a debt-to-equity ratio of 0.25 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is INNEOVA HOLD's return on assets (ROA)?

INNEOVA HOLD (INEO) had a return on assets of -1.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is INNEOVA HOLD's Piotroski F-Score?

INNEOVA HOLD (INEO) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are INNEOVA HOLD's earnings high quality?

INNEOVA HOLD (INEO) has an earnings quality ratio of -11.19x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can INNEOVA HOLD cover its interest payments?

INNEOVA HOLD (INEO) has an interest coverage ratio of -0.0x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is INNEOVA HOLD?

INNEOVA HOLD (INEO) scores 38 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.